— Know what they know.
Not Investment Advice
Also trades as: 4519.T (JPX) · $vol 102M · CHGCF (OTC) · $vol 0M

CHGCY OTC

Chugai Pharmaceutical Co., Ltd.
1W: -9.5% 1M: -11.7% 3M: -18.0% YTD: -27.7% 1Y: -17.4% 3Y: +32.7% 5Y: +4.7%
$19.08
-0.25 (-1.29%)
 
Weekly Expected Move ±4.5%
$17 $18 $19 $20 $21
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 33 · $62.8B mcap · 640M float · 0.040% daily turnover · Short 27% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
4
ROE
5
ROA
5
D/E
2
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CHGCY receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 A- B+
2026-08-03 B+ A-
2026-07-27 A- B+
2026-05-11 B+ A-
2026-04-01 A- B+
2026-03-30 B+ A-
2026-02-02 A B+
2026-01-03 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
100
Balance Sheet
97
Earnings Quality
64
Growth
73
Value
—
Momentum
86
Safety
—
Cash Flow
78

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✗ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.12
Unlikely Manipulator
Ohlson O-Score
-15.21
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.8/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 0.94x
Accruals: 1.3%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CHGCY scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CHGCY's score of -2.12 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CHGCY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CHGCY receives an estimated rating of AA- (score: 82.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CHGCY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.06x
PEG
1.10x
P/S
7.39x
P/B
4.90x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$1440.62
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.1x earnings, CHGCY commands a growth premium. Graham's intrinsic value formula yields $1440.62 per share, suggesting a potential 7450% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.745
NI / EBT
×
Interest Burden
0.976
EBT / EBIT
×
EBIT Margin
0.483
EBIT / Rev
×
Asset Turnover
0.600
Rev / Assets
×
Equity Multiplier
1.178
Assets / Equity
=
ROE
24.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CHGCY's ROE of 24.8% is driven by Asset Turnover (0.600), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
14.90%
Fair P/E
38.30x
Intrinsic Value
$5773.22
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CHGCY's realized 14.9% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CHGCY trades at a premium to its adjusted intrinsic value of $5773.22, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.3x compares to the current market P/E of 21.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$19.08
Median 1Y
$19.47
5th Pctile
$10.72
95th Pctile
$35.23
Ann. Volatility
34.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 25.4% 28.0% 34.8% 33.0% 30.9% 28.7% 23.6% 23.2% 23.7% 21.3% 21.2% 21.7% 23.2% 22.0% 23.1% 21.2% 21.4% 23.2% 24.9% 24.8% 24.81%
ROA 20.6% 21.8% 28.4% 26.8% 24.3% 22.0% 18.8% 18.9% 19.1% 17.1% 17.8% 18.2% 19.9% 18.7% 20.3% 18.2% 18.6% 19.5% 21.5% 21.1% 21.05%
ROIC 37.0% 41.6% 47.6% 54.0% 48.2% 40.2% 35.5% 38.1% 36.2% 35.2% 36.2% 37.1% 40.1% 42.1% 42.4% 40.5% 39.3% 41.3% 43.0% 45.1% 45.08%
ROCE 31.9% 34.6% 42.8% 40.9% 39.1% 36.7% 30.5% 29.9% 30.3% 26.9% 26.7% 27.5% 29.7% 28.3% 30.0% 27.7% 28.5% 30.5% 33.8% 33.4% 33.41%
Gross Margin 63.7% 65.7% 68.3% 66.1% 69.3% 51.4% 51.5% 65.7% 69.7% 66.4% 69.2% 72.2% 73.3% 68.8% 69.6% 69.6% 69.9% 74.2% 71.2% 69.7% 69.67%
Operating Margin 42.5% 43.2% 51.9% 42.4% 43.0% 34.1% 31.5% 42.1% 41.4% 41.8% 42.9% 50.1% 50.8% 40.1% 47.4% 44.0% 53.8% 43.0% 50.6% 47.0% 47.01%
Net Margin 29.9% 30.7% 36.5% 30.7% 30.1% 23.4% 23.5% 31.1% 30.1% 33.3% 31.4% 35.4% 34.7% 30.3% 33.7% 33.5% 33.4% 36.7% 35.9% 34.1% 34.06%
EBITDA Margin 41.8% 43.6% 51.7% 42.9% 42.4% 34.2% 32.1% 42.8% 41.8% 47.3% 42.3% 50.2% 50.9% 50.9% 47.5% 47.3% 52.8% 52.0% 53.3% 47.0% 47.01%
FCF Margin 20.4% 20.7% 19.1% 28.1% 26.1% 13.7% 19.6% 14.9% 14.9% 30.2% 31.3% 24.5% 30.6% 33.9% 28.8% 33.1% 29.1% 24.2% 28.5% 29.4% 29.42%
OCF Margin 28.9% 28.0% 25.7% 35.0% 32.0% 19.4% 24.7% 20.3% 20.3% 36.9% 37.0% 30.2% 36.7% 38.2% 33.8% 28.7% 24.2% 21.1% 24.8% 33.0% 32.96%
ROE 3Y Avg snapshot only 21.61%
ROE 5Y Avg snapshot only 23.24%
ROA 3Y Avg snapshot only 18.32%
ROIC 3Y Avg snapshot only 34.62%
ROIC Economic snapshot only 24.20%
Cash ROA snapshot only 19.16%
Cash ROIC snapshot only 43.34%
CROIC snapshot only 38.69%
NOPAT Margin snapshot only 34.29%
Pretax Margin snapshot only 47.10%
R&D / Revenue snapshot only 14.22%
SGA / Revenue snapshot only 8.82%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 21.059
P/S Ratio — — — — — — — — — — — — — — — — — — — — 7.393
P/B Ratio — — — — — — — — — — — — — — — — — — — — 4.895
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 1.097
Graham Number snapshot only $1440.62
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.73 3.25 3.41 3.83 3.21 3.15 3.89 4.26 4.76 4.74 5.53 5.09 5.89 5.53 7.28 6.04 5.68 4.23 4.70 4.35 4.345
Quick Ratio 2.91 2.61 2.70 3.08 2.36 2.46 3.01 3.37 3.71 3.79 4.37 4.17 4.80 4.70 6.16 5.16 4.75 3.56 3.82 3.54 3.536
Debt/Equity 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.009
Net Debt/Equity -0.36 -0.38 -0.34 -0.45 -0.41 -0.34 -0.38 -0.43 -0.40 -0.45 -0.46 -0.46 -0.47 -0.52 -0.50 -0.52 -0.46 -0.47 -0.44 -0.47 -0.466
Debt/Assets 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.007
Debt/EBITDA 0.01 0.04 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.03 0.02 0.01 0.00 0.02 0.00 0.00 0.02 0.04 0.03 0.02 0.024
Net Debt/EBITDA -1.08 -1.08 -0.77 -1.06 -1.02 -0.92 -1.22 -1.43 -1.29 -1.61 -1.68 -1.63 -1.54 -1.72 -1.55 -1.75 -1.46 -1.44 -1.20 -1.29 -1.294
Interest Coverage 6322.34 422.39 544.12 546.19 519.93 8853.78 9263.98 10903.48 13834.74 16397.22 17717.36 30453.25 60019.56 — — 9774.53 4789.15 599.96 627.68 690.10 690.100
Equity Multiplier 1.24 1.30 1.28 1.24 1.30 1.31 1.23 1.21 1.18 1.19 1.16 1.18 1.15 1.16 1.12 1.15 1.16 1.22 1.19 1.21 1.208
Cash Ratio snapshot only 2.454
Debt Service Coverage snapshot only 732.822
Cash to Debt snapshot only 54.404
FCF to Debt snapshot only 23.675
Defensive Interval snapshot only 1671.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.71 0.72 0.87 0.83 0.75 0.74 0.72 0.72 0.73 0.58 0.56 0.56 0.59 0.57 0.61 0.55 0.57 0.56 0.62 0.60 0.600
Inventory Turnover 1.57 1.72 1.94 1.96 1.45 1.90 2.03 2.17 1.81 1.46 1.21 1.24 1.22 1.32 1.39 1.41 1.42 1.47 1.48 1.47 1.470
Receivables Turnover 3.44 3.29 4.10 4.71 4.03 2.90 3.22 4.41 4.32 2.67 3.45 3.36 3.56 3.58 4.57 3.59 3.56 3.39 4.19 4.06 4.063
Payables Turnover 2.66 2.68 3.70 4.09 2.29 2.63 3.21 5.50 3.55 2.56 2.63 3.75 3.57 3.82 4.45 4.50 4.76 3.96 4.35 3.40 3.402
DSO 106 111 89 77 90 126 113 83 84 137 106 109 103 102 80 102 103 108 87 90 89.8 days
DIO 232 212 188 186 251 192 179 169 202 250 303 293 298 276 263 258 257 247 246 248 248.4 days
DPO 137 136 99 89 159 139 114 66 103 142 139 97 102 96 82 81 77 92 84 107 107.3 days
Cash Conversion Cycle 201 187 179 175 182 179 179 185 183 244 270 304 299 282 260 279 283 263 249 231 230.9 days
Fixed Asset Turnover snapshot only 2.828
Operating Cycle snapshot only 338.2 days
Cash Velocity snapshot only 1.479
Capital Intensity snapshot only 1.721
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 17.8% 27.0% 53.5% 49.0% 28.8% 26.0% 1.7% 3.1% 11.6% -11.8% -14.5% -12.8% -10.5% 5.3% 18.0% 10.3% 6.8% 12.7% 11.1% 18.2% 18.22%
Net Income 26.6% 41.1% 83.9% 68.7% 44.6% 23.6% -18.4% -15.9% -9.2% -13.1% 3.2% 8.6% 14.9% 19.0% 25.7% 11.4% 3.1% 17.5% 15.9% 25.4% 25.45%
EPS 26.6% 40.8% 83.9% 68.7% 44.6% 23.6% -18.4% -16.0% -9.2% -13.1% 3.2% 8.6% 14.9% 18.9% 25.7% 11.4% 3.1% 17.5% 15.9% 25.4% 25.45%
FCF 41.9% 44.0% 37.6% 74.5% 65.3% -16.4% 4.3% -45.5% -36.2% 94.4% 36.6% 43.7% 83.6% 18.0% 8.3% 48.9% 1.2% -19.5% 10.1% 5.1% 5.12%
EBITDA 28.8% 38.0% 81.9% 66.4% 44.0% 25.9% -18.1% -16.1% -9.8% -15.2% 1.2% 7.9% 16.3% 27.0% 35.1% 18.6% 10.5% 15.4% 14.6% 23.2% 23.15%
Op. Income 28.8% 40.1% 86.1% 70.6% 46.6% 26.4% -18.4% -16.6% -10.7% -19.0% -2.1% 5.2% 14.5% 25.3% 32.5% 13.5% 6.2% 14.4% 12.4% 25.2% 25.15%
OCF Growth snapshot only 35.70%
Asset Growth snapshot only 6.82%
Equity Growth snapshot only 1.47%
Debt Growth snapshot only 191.29%
Shares Change snapshot only -0.00%
Dividend Growth snapshot only 1.80%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 15.7% 19.9% 26.6% 25.2% 20.0% 22.5% 19.4% 19.2% 19.2% 12.2% 10.1% 10.3% 8.8% 5.4% 0.8% -0.3% 2.2% 1.5% 3.9% 4.4% 4.38%
Revenue 5Y 12.5% 15.2% 19.1% 19.4% 17.2% 18.7% 16.9% 17.0% 17.4% 13.9% 12.0% 12.0% 11.5% 11.3% 11.4% 10.3% 10.1% 10.9% 11.8% 11.8% 11.82%
EPS 3Y 44.0% 48.4% 57.2% 50.9% 38.5% 33.3% 22.0% 19.7% 18.4% 14.8% 15.7% 15.5% 14.7% 8.5% 1.9% 0.5% 2.5% 6.7% 14.6% 14.9% 14.90%
EPS 5Y 35.2% 41.3% 46.3% 46.2% 40.5% 38.7% 30.9% 30.8% 31.4% 28.5% 26.8% 25.7% 22.6% 19.6% 18.7% 15.7% 14.5% 16.2% 17.7% 16.6% 16.55%
Net Income 3Y 44.0% 48.5% 57.2% 51.0% 38.5% 33.4% 22.0% 19.7% 18.5% 14.9% 15.7% 15.5% 14.7% 8.5% 1.9% 0.5% 2.5% 6.7% 14.6% 14.9% 14.91%
Net Income 5Y 35.3% 41.4% 46.4% 46.2% 40.5% 38.8% 31.0% 30.8% 31.4% 28.6% 26.8% 25.7% 22.6% 19.7% 18.7% 15.7% 14.5% 16.2% 17.7% 16.6% 16.56%
EBITDA 3Y 45.5% 51.6% 61.6% 53.9% 41.6% 35.4% 22.9% 20.8% 18.7% 13.8% 14.7% 14.6% 14.8% 10.7% 3.8% 2.4% 5.0% 7.5% 16.1% 16.4% 16.39%
EBITDA 5Y 35.7% 41.5% 47.0% 48.0% 42.1% 40.6% 32.4% 31.8% 32.0% 30.0% 28.4% 27.0% 24.4% 21.7% 20.4% 17.7% 16.6% 16.6% 18.5% 17.1% 17.10%
Gross Profit 3Y 23.7% 27.8% 34.9% 31.1% 25.2% 23.1% 16.0% 15.7% 14.9% 10.8% 11.3% 11.5% 11.0% 7.9% 3.0% 1.9% 3.2% 6.2% 11.6% 12.0% 12.00%
Gross Profit 5Y 18.9% 22.1% 26.1% 25.8% 23.6% 22.9% 18.5% 18.7% 19.0% 17.1% 16.7% 16.4% 15.5% 14.6% 14.1% 12.6% 11.6% 12.8% 13.8% 13.2% 13.16%
Op. Income 3Y 43.5% 50.3% 60.4% 53.1% 40.8% 36.3% 23.3% 21.3% 19.0% 12.8% 14.1% 14.4% 14.4% 8.7% 1.9% -0.1% 2.8% 5.1% 13.4% 14.3% 14.31%
Op. Income 5Y 35.4% 40.6% 45.6% 46.8% 40.8% 40.1% 32.0% 31.0% 31.1% 28.3% 26.9% 25.8% 23.3% 20.8% 19.5% 16.3% 15.4% 15.5% 17.2% 16.3% 16.28%
FCF 3Y 25.5% 70.9% 1.1% 98.6% 53.1% 5.9% 26.9% 19.6% 14.4% 32.8% 25.2% 11.0% 24.6% 24.2% 15.6% 5.3% 5.8% 22.7% 17.7% 31.0% 31.02%
FCF 5Y 1.1% 1.4% 60.7% 58.4% 70.0% 22.3% 24.0% 17.2% 15.8% 52.0% 68.6% 43.8% 33.2% 22.2% 24.8% 29.7% 22.7% 17.3% 18.5% 16.4% 16.44%
OCF 3Y 26.9% 32.9% 44.5% 52.6% 31.7% 5.7% 18.8% 8.7% 7.0% 26.0% 15.9% 9.0% 17.8% 17.0% 10.6% -6.7% -6.9% 4.4% 4.0% 22.7% 22.66%
OCF 5Y 44.5% 48.4% 44.1% 44.4% 41.9% 17.8% 18.6% 15.9% 15.5% 28.1% 30.5% 22.4% 21.2% 16.7% 18.3% 11.8% 6.9% 6.3% 6.4% 13.0% 13.03%
Assets 3Y 15.0% 18.7% 19.4% 18.1% 18.4% 20.9% 19.2% 19.5% 17.0% 16.1% 18.4% 17.3% 15.2% 12.8% 10.5% 11.9% 9.3% 9.7% 8.7% 9.9% 9.94%
Assets 5Y 11.9% 13.8% 14.7% 14.6% 15.8% 17.0% 15.7% 16.0% 15.3% 16.0% 15.3% 15.9% 15.1% 15.8% 15.4% 16.3% 14.3% 14.9% 14.7% 13.8% 13.79%
Equity 3Y 13.9% 16.3% 17.7% 18.2% 17.2% 18.6% 18.9% 18.7% 18.4% 18.4% 18.7% 18.5% 18.2% 17.0% 15.4% 14.9% 13.6% 12.5% 10.1% 10.0% 10.00%
Book Value 3Y 13.8% 16.2% 17.7% 18.2% 17.2% 18.5% 18.9% 18.6% 18.4% 18.3% 18.7% 18.5% 18.2% 17.0% 15.4% 14.9% 13.6% 12.5% 10.1% 10.0% 10.00%
Dividend 3Y 2.5% 2.5% 11.3% 11.4% 11.9% 11.8% 1.0% 0.8% -1.6% -1.7% 0.7% 0.8% 0.4% 0.4% 7.2% 7.2% 31.7% 31.3% 41.1% 41.0% 40.96%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.94 0.90 0.79 0.83 0.92 0.91 0.87 0.89 0.96 0.85 0.67 0.71 0.82 0.71 0.54 0.52 0.66 0.68 0.78 0.76 0.759
Earnings Stability 0.94 0.93 0.86 0.90 0.95 0.97 0.84 0.87 0.93 0.89 0.73 0.79 0.89 0.84 0.68 0.70 0.82 0.83 0.67 0.71 0.705
Margin Stability 0.88 0.88 0.88 0.89 0.89 0.91 0.91 0.91 0.91 0.93 0.91 0.91 0.92 0.94 0.92 0.92 0.93 0.93 0.92 0.92 0.918
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.89 0.84 0.50 0.50 0.82 0.91 0.93 0.94 0.96 0.95 0.99 0.97 0.94 0.92 0.90 0.95 0.99 0.93 0.94 0.90 0.898
Earnings Smoothness 0.77 0.66 0.41 0.49 0.64 0.79 0.80 0.83 0.90 0.86 0.97 0.92 0.86 0.83 0.77 0.89 0.97 0.84 0.85 0.77 0.774
ROE Trend 0.04 0.05 0.10 0.08 0.06 0.03 -0.04 -0.04 -0.04 -0.06 -0.07 -0.05 -0.04 -0.03 0.01 -0.01 -0.01 0.02 0.04 0.05 0.045
Gross Margin Trend 0.04 0.03 0.02 0.01 0.02 -0.04 -0.08 -0.09 -0.09 -0.01 0.06 0.08 0.08 0.09 0.08 0.07 0.05 0.04 0.02 0.01 0.015
FCF Margin Trend 0.06 0.01 0.00 0.09 0.08 -0.06 -0.01 -0.11 -0.08 0.13 0.12 0.03 0.10 0.12 0.03 0.13 0.06 -0.08 -0.02 0.01 0.006
Sustainable Growth Rate 15.7% 18.9% 23.6% 22.4% 19.4% 18.1% 14.0% 14.1% 14.4% 12.7% 12.7% 13.7% 15.2% 14.4% 14.0% 12.5% 5.1% 7.8% 1.1% 2.2% 2.17%
Internal Growth Rate 14.5% 17.3% 23.8% 22.2% 18.0% 16.1% 12.6% 13.0% 13.2% 11.4% 11.9% 13.0% 15.0% 14.0% 14.0% 12.1% 4.6% 7.0% 0.9% 1.9% 1.88%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.00 0.92 0.79 1.09 0.99 0.65 0.95 0.77 0.77 1.26 1.17 0.92 1.08 1.16 1.01 0.87 0.74 0.61 0.71 0.94 0.940
FCF/OCF 0.70 0.74 0.75 0.80 0.82 0.71 0.79 0.73 0.74 0.82 0.85 0.81 0.83 0.89 0.85 1.15 1.20 1.15 1.15 0.89 0.893
FCF/Net Income snapshot only 0.839
OCF/EBITDA snapshot only 0.643
CapEx/Revenue 8.6% 7.3% 6.5% 6.9% 5.9% 5.7% 5.1% 5.4% 5.3% 6.7% 5.8% 5.7% 6.2% 4.5% 5.0% 5.5% 4.9% 5.9% 5.0% 3.5% 3.54%
CapEx/Depreciation snapshot only 1.184
Accruals Ratio -0.00 0.02 0.06 -0.02 0.00 0.08 0.01 0.04 0.04 -0.04 -0.03 0.01 -0.02 -0.03 -0.00 0.02 0.05 0.08 0.06 0.01 0.013
Sloan Accruals snapshot only -0.038
Cash Flow Adequacy snapshot only 0.927
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 3.53%
Dividend/Share $29.94 $29.98 $37.91 $38.01 $41.97 $42.00 $39.03 $38.98 $40.00 $39.98 $39.86 $39.89 $40.50 $40.47 $49.12 $49.10 $92.63 $91.64 $138.13 $137.53 $106.50
Payout Ratio 38.4% 32.6% 32.2% 32.2% 37.2% 36.9% 40.6% 39.2% 39.1% 40.4% 40.2% 37.0% 34.5% 34.4% 39.4% 40.9% 76.4% 66.3% 95.6% 91.2% 91.25%
FCF Payout Ratio 54.5% 47.7% 54.7% 36.9% 46.2% 80.0% 54.0% 69.3% 69.0% 39.2% 40.4% 49.4% 38.1% 33.6% 46.0% 40.8% 86.0% 94.5% 1.2% 1.1% 1.09%
Total Payout Ratio 38.4% 32.6% 32.2% 32.2% 37.3% 36.9% 40.6% 39.2% 39.1% 40.4% 40.2% 37.0% 34.5% 34.4% 39.4% 40.9% 76.4% 66.3% 95.6% 92.1% 92.06%
Div. Increase Streak 1 1 1 1 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 1 1
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.72 0.72 0.72 0.71 0.71 0.70 0.71 0.71 0.72 0.73 0.73 0.73 0.72 0.71 0.71 0.71 0.72 0.75 0.75 0.74 0.745
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.96 0.96 0.98 0.976
EBIT Margin 0.40 0.42 0.45 0.45 0.46 0.42 0.37 0.37 0.37 0.40 0.43 0.45 0.47 0.46 0.47 0.47 0.46 0.48 0.48 0.48 0.483
Asset Turnover 0.71 0.72 0.87 0.83 0.75 0.74 0.72 0.72 0.73 0.58 0.56 0.56 0.59 0.57 0.61 0.55 0.57 0.56 0.62 0.60 0.600
Equity Multiplier 1.23 1.28 1.23 1.23 1.27 1.30 1.25 1.23 1.24 1.25 1.19 1.19 1.17 1.17 1.14 1.16 1.15 1.19 1.15 1.18 1.178
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $77.93 $92.08 $117.72 $118.22 $112.68 $113.78 $96.07 $99.35 $102.32 $98.89 $99.17 $107.87 $117.56 $117.63 $124.60 $120.15 $121.26 $138.25 $144.42 $150.72 $150.72
Book Value/Share $331.43 $361.04 $376.99 $397.29 $397.70 $432.85 $436.65 $459.84 $466.41 $493.93 $498.92 $532.22 $547.25 $577.51 $579.42 $603.14 $583.42 $615.87 $582.09 $611.99 $616.08
Tangible Book/Share $323.90 $354.36 $369.43 $389.53 $389.69 $425.21 $430.67 $453.55 $460.34 $487.89 $492.98 $526.04 $540.92 $572.08 $574.16 $593.02 $572.88 $599.29 $564.25 $594.10 $594.10
Revenue/Share $269.82 $303.83 $362.10 $366.40 $347.58 $382.88 $368.19 $377.83 $387.73 $337.69 $314.80 $329.53 $347.04 $355.53 $371.28 $363.44 $370.52 $400.71 $412.61 $429.67 $408.00
FCF/Share $54.96 $62.83 $69.25 $103.09 $90.86 $52.53 $72.23 $56.22 $57.93 $102.10 $98.66 $80.79 $106.36 $120.38 $106.85 $120.27 $107.66 $96.93 $117.63 $126.43 $123.03
OCF/Share $78.06 $84.98 $92.88 $128.41 $111.25 $74.18 $90.96 $76.76 $78.61 $124.66 $116.51 $99.48 $127.52 $135.94 $125.58 $104.38 $89.66 $84.40 $102.32 $141.64 $137.81
Cash/Share $120.53 $143.43 $131.23 $179.98 $165.72 $152.89 $168.54 $202.06 $188.01 $224.54 $232.31 $247.82 $256.80 $302.60 $286.96 $312.22 $272.39 $297.85 $259.39 $290.53 $292.47
EBITDA/Share $110.48 $128.68 $165.75 $166.59 $159.14 $161.95 $135.70 $139.76 $143.47 $137.30 $137.33 $150.79 $166.88 $174.23 $185.45 $178.90 $184.42 $201.12 $212.53 $220.32 $220.32
Debt/Share $1.52 $4.87 $3.07 $2.81 $2.85 $4.29 $2.48 $2.31 $2.56 $4.09 $2.08 $2.00 $0.00 $3.31 $0.00 $0.03 $3.74 $7.82 $5.34 $5.34 $5.34
Net Debt/Share $-119.02 $-138.56 $-128.17 $-177.17 $-162.87 $-148.60 $-166.06 $-199.76 $-185.45 $-220.45 $-230.23 $-245.82 $-256.80 $-299.29 $-286.96 $-312.19 $-268.65 $-290.04 $-254.04 $-285.19 $-285.19
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 5 5 5 5 6 5 4 4 6 6 6 6 7 7 8 6 4 6 6 6 6
Beneish M-Score -2.11 -1.92 -1.15 -2.36 -2.45 -1.52 -2.29 -2.20 -2.17 -3.20 -3.14 -2.25 -2.48 -2.58 -2.25 -2.39 -1.88 -1.79 -1.82 -2.12 -2.122
Ohlson O-Score snapshot only -15.213
ROIC (Greenblatt) snapshot only 37.86%
Net-Net WC snapshot only $386.92
EVA snapshot only $377322024558.94
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 82.75 80.00 80.25 80.00 82.75 82.75 82.75 82.75 82.75 82.750
Credit Grade snapshot only 4
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms